TradingView
RocketTickers
Aug 17, 2020 4:56 PM
Immunomedics Announces FDA Approval of Samsung Biologics as Anti
Long
NASDAQ:IMMU
15
Description
⋅
Aug 17, 2020 4:56 PM
IMMU: Immunomedics
2020-08-17 08:00:10
Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
Beyond Technical Analysis
Comments
aaronsmth5
⋅
Aug 18, 2020 11:33 PM
go to biopharmcatalyst.com and look up all the other big announcements coming, stay long my friend
More